← All companies

ALEC

Alector, Inc.

ALEC Nasdaq Biological Products, (No Diagnostic Substances) EDGAR ↗

$1.51

-0.11 -6.79%

Key statistics

from XBRL data in SEC filings

Market cap

$168M

Revenue (TTM)

$18.4M

Net income (TTM)

-$125M

EPS (TTM)

$-1.19

P/E ratio

—

Dividend yield

—

Free cash flow

-$184M

Cash

$77.0M

Total assets

$240M

Gross margin

—

52-week range

$1.09 – $3.40

Recent SEC filings

40 most recent

Annual, quarterly & current reports

8-K Terminated a material agreement Jul 8, 2026 8-K Shareholder vote results Jun 17, 2026 8-K Entered a material agreement May 7, 2026 10-Q Quarter ended 2026-03-31 May 7, 2026 8-K Results of operations (earnings release) May 7, 2026 10-K Fiscal year ended 2025-12-31 Feb 25, 2026 8-K Results of operations (earnings release) Feb 25, 2026 8-K Director or officer change Dec 12, 2025 10-Q Quarter ended 2025-09-30 Nov 6, 2025 8-K Results of operations (earnings release) Nov 6, 2025 8-K Results of operations (earnings release); Exit or disposal costs; Director or officer change; Regulation FD disclosure Oct 21, 2025 10-Q Quarter ended 2025-06-30 Aug 7, 2025 8-K Results of operations (earnings release) Aug 7, 2025 8-K Director or officer change; Shareholder vote results Jun 13, 2025 10-Q Quarter ended 2025-03-31 May 8, 2025 8-K Results of operations (earnings release) May 8, 2025 8-K Director or officer change Mar 28, 2025 8-K Exit or disposal costs Mar 10, 2025 10-K Fiscal year ended 2024-12-31 Feb 26, 2025 8-K Results of operations (earnings release) Feb 26, 2025 8-K Other events Jan 10, 2025 8-K Exit or disposal costs; Regulation FD disclosure Nov 25, 2024 8-K Entered a material agreement; Took on a direct financial obligation; Regulation FD disclosure Nov 14, 2024 10-Q Quarter ended 2024-09-30 Nov 6, 2024 8-K Results of operations (earnings release) Nov 6, 2024 10-Q Quarter ended 2024-06-30 Aug 7, 2024 8-K Results of operations (earnings release) Aug 7, 2024 8-K Shareholder vote results Jun 12, 2024 10-Q Quarter ended 2024-03-31 May 8, 2024 8-K Results of operations (earnings release) May 8, 2024 8-K Director or officer change Mar 21, 2024 10-K Fiscal year ended 2023-12-31 Feb 27, 2024 8-K Results of operations (earnings release) Feb 27, 2024 8-K Entered a material agreement; Other events Jan 19, 2024 8-K Results of operations (earnings release) Jan 16, 2024 8-K Entered a material agreement Nov 7, 2023 10-Q Quarter ended 2023-09-30 Nov 7, 2023 8-K Results of operations (earnings release) Nov 7, 2023 10-Q Quarter ended 2023-06-30 Aug 3, 2023 8-K Results of operations (earnings release) Aug 3, 2023